KRISTEN CURTIS: Open Payments
NPI 1407806037 · RICHBORO, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 19 payments from 9 companies in 2025. Trend: 2023 $588 · 2024 $526 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $74 |
| PFIZER INC. | 4 | $68 |
| Novo Nordisk Inc | 3 | $67 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Amgen Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $22 |
| Bausch Health US, LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: VRAYLAR, SHINGRIX, NURTEC ODT, REPATHA, MOUNJARO, APLENZIN, FARXIGA, REXULTI.
Industry payments across PA — which companies pay providers there.
